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Abstract  
Introduction: Epilepsy is the most common of serious neurological disorders, yet despite considerable efforts, good access to medication, 
appropriate social and societal acceptance and acceptable quality of life (QoL) are difficult to achieve especially in developing countries. It is 
estimated that over 500,000 people suffer from epilepsy in the DRC. There is no report, in our knowledge on the epilepsy in Lubumbashi. 
Methods: A descriptive study was undertaken in individuals with a clinical diagnosis of epilepsy who presented at the CNPJG outpatient clinic in 
Lubumbashi over a 12 months period. A 64-item questionnaire was used to collect information from the patients. Case records were reviewed and 
relevant demographic, social, professional, medical history, medical condition data were extracted. Results: Among 3,540 patients who presented 
to a neuropsychiatric clinic run by the Fracarita charity over a 1-year period, 423 (11.9%) were identified as having epilepsy, and 179 were 
subsequently included in the survey after they (or their parent/guardian) provided informed consent and completed an EEG investigation. Data 
were collected using a standardized, 64-item questionnaire. Epilepsy had negative impact on the lives of individuals with the condition; 40.8% had 
either no education or had completed primary education only, 38.0% were unemployed and the majority (64.6%; n=113) were unmarried or 
divorced. Family history of epilepsy (first or second degree) was present in 23.5% of cases. Other reported factors that could potentially precipitate 
epilepsy included obstetric and perinatal factors (15.1%) and central nervous system infections during infancy (8.4%). Consumption of alcohol or 
recreational drugs accounted for 10.6%. The treatment gap was above 67% and the delay between first seizure and first consultation was 15 
months. When asked to describe their condition, or its cause, 55.3% of participants (or their families) considered epilepsy to be of spiritual/ 
religious origin, while 25.1% had almost no insight and could not provide any description. Conclusion: This first epidemiological study shows a 
high prevalence of epilepsy among patients presenting to the clinic in Lubumbashi, DRC, and reveals a significant treatment gap. 
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Introduction 
 
Epilepsy is the most common of serious neurological disorders, yet 
despite considerable efforts, good access to medication, appropriate 
social and societal acceptance and acceptable quality of life (QoL) 
are difficult to achieve. Attaining these goals in developing 
countries, where approximately 80% of people with epilepsy (PwE) 
live [1], presents even greater challenges. The prevalence of 
epilepsy in sub-Saharan Africa and Latin America is particularly high; 
15.0 and 17.8 per 1,000 people, respectively, compared with 6 per 
1,000 in Asia and lower to 8 per 1,000 in Europe and North America 
[2]. The first, and to our knowledge, only epidemiological data on 
epilepsy from the Democratic Republic of Congo (DRC) were 
published in 1970 [3]. Of 4,400 people seen at the Neurology 
Department of the University Hospital of Lovanium in Kinshasa, 865 
were identified as having epilepsy (19.7%). A preliminary analysis of 
300 patients demonstrated that more than half experienced 
generalised convulsions. The same team published data on 1,356 
consultations at the paediatric neurology department in the period 
between January 1975 and October 1976 with a total of 310 
convulsions observed in children up to 6 years of age [4]. 
Lubumbashi is the capital of the southern province of Katanga, and 
with a population of over 1.5 million, it is the second most important 
city in the DRC, after the capital, Kinshasa. It is the major 
commercial and industrial hub of the country, given it rich mineral 
resources. In 2007, the Centre Neuro-Psychiatrique Joseph Guislain 
(CNPJG) was established in the city by the Brothers of Charity 
(Fracarita Belgium). The charity is primarily active in the fields of 
mental health, care for people with a disability and education and 
training in 32 countries worldwide. Since 2010, healthcare workers 
at CNPJG have been specifically focusing on epilepsy, not only in 
treating patients with the conditions, but also raising awareness 
through educational programmes. In this epidemiological study we 
sought to document several elements; the number of patients 
presenting to the neuropsychiatric clinic of brothers of charity with 
epilepsy and their characteristics, potential risk and aetiological 






A descriptive study was undertaken in individuals with a clinical 
diagnosis of epilepsy who presented at the CNPJG outpatient clinic 
in Lubumbashi over a 12 months period, from May 2010 to April 
2011. Patients were deemed eligible for analysis if they were over 6 
years old and if they agreed to undergo electroencephalography 
(EEG). When possible, a CT scan has been realised. It was only for 
people who have financial possibilities with a clinical status indicate 
this exam. All patients provided informed consent before inclusion in 
the study. A 64-item questionnaire was used to document 
demographic data, and other information such as education level, 
societal status, religion, medical history, characteristics of epileptic 
seizures, time to diagnosis, current and previous treatment, 
including traditional healing, and access to anti-epileptic drugs 
(AEDs). Data were collected by the treating physician. Case records 
were reviewed and relevant demographic, social, professional, 
medical history, medical condition data were extracted. Each patient 
underwent general physical and neurological examination and 
eligible patients had realised an EEG. Demographic and epilepsy-
related data were analysed using descriptive statistics (Epi 
InfoTM version 3.5.1 (CDC, Atlanta, USA)). Continuous variables 
were summarized as mean ± standard deviation if normally 
distributed. Median was used for non-normally distributed variables. 
Categorical variables were summarized as proportions and 
frequencies. The Chi square and KRUSKAL-WALLIS test were used 
to compare differences between groups. Treatment gap was defined 
as the difference between the number of people with active epilepsy 
and the number of those receiving appropriate treatment at the 





During the 12-month observation period, 3,540 patients presented 
at the CNPJG with different neuro-psychiatric conditions of whom 
423 (11.9%) were identified as having epilepsy; 239 (56.4%) were 
male and 184 (43.6%) female. Of the person living with epilepsy, 
179 were included in the survey after they provided informed 
consent and completed an EEG investigation. The mean age of the 
study population was 21.5 years, range 6 - 106 years (Table 1). 
Whereas 88% lived in Lubumbashi, only 55.3% of the patients were 
originally from the province of Katanga. A total of 40.8% had either 
no education or had completed primary education only and 38.0% 
were unemployed. Of 113 patients who were questioned about 
marital status 75 (64.6%) were unmarried, divorced or single. A 
family history of epilepsy (first or second degree) was present in 23, 
5% of cases, suggesting a genetic pathology in some patients 
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(Table 2). Epilepsy was observed more frequently among first-born 
children (57%), than in second- and third-born (14.0% and 16.2%, 
respectively). Other factors that could have potentially contributed 
to the development of epilepsy were obstetric and perinatal factors 
in 15.1% of patients, followed by central nervous system infections 
during infancy (8.4%). Of interest is the consumption of alcohol or 
recreational drugs such as cannabis accounting for 10.6%. Over 
60% of patients could not recall a precipitating factor for their 
condition. When asked to describe their condition, 12.8% provided a 
good description - i.e., kifwafwa (tonic-clonic seizures), ndeke (crisis 
with foam to the lips), musanfu (febrile convulsions in children). 
  
In contrast, 55.3% of PwE considered their condition to be of 
spiritual and/or religious origin. An additional 6.7% of patients 
confused malaria with epilepsy. One out of four patients (25.1%) 
could not provide any description. Generalised tonic-clonic seizures 
were the most frequently reported type of seizure (57.5%), while 
the other clinical presentations of epilepsy all remained below 10%. 
The EEG was taken within 72 hours after the last seizure, with 
66.5% showing abnormalities (Table 3). In total, 171 abnormalities 
were counted in 119 patients with an abnormal EEG. Abnormal slow 
waves were noted in 51 patients, while fast waves were noted in 
only 5 patients. Focal slow waves and diffuse slow waves were 
observed in 44 and 31 patients, respectively. Focal spikes (or sharp 
waves) were seen in 32 patients, whereas diffuse or generalised 
spikes were seen in 7 patients and 1 patient, respectively. Thirty-
seven patients have undergone a CT scan. In 59.5% no 
abnormalities were noted. Among the remaining patients with 
abnormal scans, ischemic cerebrovascular accidents were the most 
frequent observation (18.9%). At the time of the first presentation 
at the CNPJG, only 33% of participants had received AEDs (Table 
4) indicating a treatment gap of 67%. Of the remaining patients, 
30% had received no treatment at all, 20% had received incorrect 
treatment (e.g., antimalarials, antibiotics), while 16.8% had 
received traditional treatment. Both religion and province didn't 
contribute to treatment choice. A total of 179 patients received 
treatment at the centre. The vast majority of patients (92.2%) 
received monotherapy, with valproate being the most commonly 
used AED (48.6%), followed by carbamazepine (23.5%) and 
levetiracetam (17.3%). Most patients continued their treatment 
(79.9%) and most achieved good seizure control (82.0%). The most 
frequently reported treatment-emergent adverse events were 
somnolence (62%), slowing of motor and cognitive function (48%) 





Epilepsy is the most common neurological condition worldwide, 
however, prevalence and incidence data are often lacking in low-
income countries. Only historical epidemiological data are available 
for epilepsy in the DRC [3, 4]. Results from our study at the CNPJG 
in Lubumbashi, established the prevalence of epilepsy among a 
population of patients with neurological disorders as 11.9%. This 
result should not be confounded with prevalence data in the general 
population in Sub-Saharan Africa, which varies significantly from 
study to study, ranging from 2.91 to 14 per 1000 [5-8]. Such 
variability could arise from numerous factors, including differences 
in definitions; nature of epilepsy studied (lifetime vs. active); sample 
size; timing and method of sampling and the sample itself, i.e, 
children vs. Adults; general population vs. Population attending 
specialised centers; rural vs. urban population; clinical vs. 
technically confirmed epilepsy; qualification of healthcare 
professionals involved in the study and finally prevalence of 
infectious diseases or other conditions with epilepsy-related 
sequelae, such as brain trauma or stroke [2, 6, 7, 9, 10]. Epilepsy 
has a profound impact on the quality of life of individuals affected 
and their family. Many affected children and adolescents are 
excluded from schooling, as illustrated in our population with over 
40% having received no education or only finishing primary 
education levels. Also, many PwE and parents caring for the children 
with epilepsy have limited financial resources to seek adequate care 
or diagnosis and to purchase AEDs. The negative impact of epilepsy 
on the ability of individuals to form long-lasting relationships was 
also shown in our study; among 113 individuals who were 
questioned about their marital status, the majority (64.6%) reported 
being unmarried or divorced. A clear description of patients' 
condition was provided by the individual patient in only 12.8% of 
cases, which is in line with the findings of a study conducted in a 
tertiary health facility in south western Nigeria, where only 10.9% of 
patients had any insight into the aetiology of their condition [11]. 
Lack of adequate knowledge about their condition render PwE 
vulnerable to myths, stigma and exclusion from their social and 
family networks [12]. Over 60% of participants considered their 
condition to have a spiritual or religious origin or confounded their 
condition with malaria. Importantly, 25.1% ignored the presence of 
a neurological condition altogether. 
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The development of epilepsy is strongly associated with adverse 
perinatal and obstetric factors. In our study, 15% of participants 
reported an abnormal delivery or prematurity, in line with published 
data [5, 13]. Perinatal and obstetric problems are important risk 
factors for developing epilepsy in low-income countries. Maternal 
hygiene and nutrition, obstetric practices and location of delivery 
(home vs healthcare center) are among the important factors 
influencing the outcome of the delivery [2]. It is of interest to note 
that epilepsy was observed more frequently in first-born children. 
This high prevalence of epilepsy among the firstborn could be 
explained by the lack of experience of young mothers in recognition 
of the evolution of a parturition leading to births at home or in 
vehicles during the transfer to a maternity in precarious conditions 
and thus traumatic for the newborn with probably head injuries as a 
cause for epilepsy. Other studies have also reported respectively 
7.1% and 20% head injuries as cause of epilepsy [13, 14]. Alcohol 
consumption as cause of epilepsy was lowers (9%) than reported in 
literature, for example 12% reported in southeast Nigeria [14]. In 
our study, we report an epilepsy treatment gap of at least 67% in 
the city of Lubumbashi, based on our observation that only 33% of 
participants had received AEDs at the time of their first presentation 
at the CNPJG. Furthermore, the dosage, dosing schedule and 
indication of the AEDs were not always appropriate and adjustments 
were needed. The 67% treatment and access gap is in line with the 
reported 75% of PwE living in low-income countries being untreated 
[15-17]. Over 30% of study participants had at some stage been 
seen by traditional healers and had received traditional herbal 
medicine (i.e., roots, barks and leaves of trees and plants) or were 
treated with rites and prayers. This is consistent with findings from 
Northern Tanzania [18] and Cameroon [19]. In Cameroon, it was 
documented that PwE consider healers to have a good 
understanding of epilepsy and their attitude toward PwE is deemed 
satisfactory. Participants' religion and province of origin did not 
influence their decision to receive traditional treatment. In terms of 
religion, protestants and pentecostalists were more likely than 
catholics to use traditional medicine (23.5% and 12.7%, 
respectively), while 21.1% of participants from Katanga compared 
with 11.7% from Kasai used traditional medicine but there was no 
statistically significant difference( P=0,08 and 0,126). In our study, 
an average gap of 15 months between the first visit to the 
traditional healer and the neurologist at the CNPJG was found. Of 
the 179 participants in our study, 82% achieved good seizure 
control. The majority of treated patients (79.9%) continued their 
AED therapy. Reasons for discontinuation included poverty, 
negligence, spiritual or religious belief and adverse events. The 
most frequently reported AED-related adverse events were 
somnolence and slowing of motor and cognitive function. Further 
research is required to evaluate the use of AED treatment in Africa, 
including potential metabolic interactions with concurrent infectious 
diseases or drug. This could potentially have a negative impact on 
therapeutic efficacy of the drugs with direct consequences for public 





Despite the limitations of the study, our results indicate the high 
prevalence of epilepsy in Lubumbashi and the important treatment 
gap. The latter is most likely to be higher in rural areas around the 
provincial capital, as access to adequate and continuous healthcare, 
as well as access and adherence to treatment are more limited. Our 
results also highlight the need to reduce the time interval between 
the first visit to a traditional healer and the first consultation at a 
specialised centre. Significant efforts are currently under way to 
reduce this delay in diagnosis and subsequent treatment. Well 
directed health educational programmes about the causes of 
epilepsy and the treatment of PwE can play an important role in 
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Table 1: Demographic characteristics of study participants 
Demographic characteristics N=179 
Age [years, mean (range)] 21.5 (6 - 106) 
Gender male / female [number (%)] 
 
Male 101 (56.4) 
Female 78 (43.6) 
Education [number (%)] 
 
No 29 (16.2) 
Primary school 44 (24.6) 
Secondary school 83 (46.4) 
High school or university 23 (12.8) 
Province of origin [number (%)] 
 
Katanga 99 (55.3) 
Kasai 60 (33.5) 
Kivu 10 (5.6) 
Bandundu 3 (1.7) 
Equator 1 (0.6) 
Bas-Congo 2 (1.1) 
Others 4 (2.2) 
Marital status [number (%)] of 113 PwE 
 
Married (total /male / female) 38(33.6) / 19 (16.8) / 19 (16.8) 
Single (total /male / female) 73 (64.6) / 46 (40.7) / 27 (23.9) 
Occupation [number (%)] 
 
Without employment 68 (38.0) 
Student 71 (39.7) 
Craftsman 11 (6.1) 
Self-employed 17 (9.5) 
Trade/business 12 (6.7) 
Religion [number (%)] 
 
Catholic 71 (39.7) 
Protestant 85 (47.5) 
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Table 2: Medical history and types of seizure experienced by study participants 
Clinical parameters N=179 
Medical history n (%) 
Family history of epilepsy 42 (23.5) 
Alcohol consumption 16 (8.9) 
Meningo-encephalitis 15 (8.4) 
Perinatal suffering 14 (7.8) 
Prematurity 13 (7.3) 
Others (neonatal icterus, Sickle-cell disease)  9 (5.0) 
Head injury 6 (3.4) 
Presence of a neurological condition 4 (2.2) 
Use of recreational drugs 3 (1.7) 
Not known 57 (31.8) 
Seizure type   
Tonic-clonic generalised 103 (57.5) 
Partial complex 17 (9.5) 
Partial secondary generalised 16 (8.9) 
Partial simple 14 (7.8) 
Variable crisis 12 (6.7) 
Atonic crisis 10 (5.6) 
Absences 6 (3.4) 
Hyperkinetic crisis 1 (0.6) 
Precipitating factors   
Emotions 15 (8.4) 
Ending AED treatment 12 (6.7) 
Others (fever, strong odors, etc) 12 (6.7) 
Menses 8 (4.5) 
During sleep 8 (4.5) 
Alcohol intoxication 6 (3.4) 
Use of recreational drugs  4 (2.2) 
After sleep deprivation 3 (1.7) 
After awakening 2 (1.1) 
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Table 3: Results of neurological investigations 
EEG parameters   
Waves n (%) 
Normal 60 (33.5) 
Abnormal 119 (66.5) 
Wave pattern   
Abnormal slow waves 51 
Abnormal fast waves 5 
Focal slow waves 44 
Diffuse slow waves 31 
Focal spikes 32 
Diffuse spikes 7 
Generalised spikes 1 
CT-scan 37 (100) 
Ischemic cerebrovascular accident 7 (18.9) 
Cerebral atrophy 2 (5.4) 
Multifocal hyperdensities 2 (5.4) 
Syndrome of Fahr 1 (2.7) 
Astrocytoma 1 (2.7) 
Tuberculoma 1 (2.7) 
Sinusitis 1 (2.7) 
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Table 4: Treatment-related parameters 
Treatment Number (%) 
Treatment received prior to first consultation 179 
AED 59 (33.0) 
None 54 (30.2) 
Incorrect, e.g., antimalarias, antibiotics 36 (20.0) 
Traditional 30 (16.8) 
Traditional treatment by religion 29 
Catholicism 9 (12.7) 
Protestantism, Pentecostalism 20 (23.5) 
Others 0 (0) 
Traditional treatment by province 28 
Katanga 21 (21.1) 
Kasai 7 (11.7) 
Treatment received at CNPJG 179 
Monotreatment 165 (92.2) 
Valproate 87 (48.6) 
Carbamazepine 42 (23.5) 
Levetiracetam 31 (17.3) 
Phenobarbital 4 (2.2) 
Phenytoin 1 (0.6) 
Combination treatment 14 (7.8) 
Continuation of treatment received at CNPJG 179 
Yes 143 (79.9) 
No 36 (20.1) 
Adverse events of AED treatment   
Somnolence 62 
Slower motor and cognitive capacity 48 
Ataxia 18 
Hyperactivity 5 
Others, e.g., vertigo, fatigue, weight gain 24 
  
 
